Dr. Lawrence Kauvar
SVP AND CSO, TRELLIS BIOSCIENCE LLC
Redwood City, California, United States
Trellis Bioscience, LLC was founded in 2010 by Dr. Lawrence Kauvar, Senior Vice President and Chief Scientific Officer. A team of experienced pharma and biotech executives with complementary skills is responsible for running the company. Dr. Kauvar was previously the founder and Chief Scientific Officer of Telik, a publically traded small molecule drug company focused on oncology (acquired by MabVax in 2014), and a co-founder of Promedior, a clinical stage anti-fibrotic company. He holds over 50 US patents for methods, tools and drug compounds and is one of the inventors of CellSpot™, Trellis' core technology. Dr. Kauvar holds an undergraduate degree in Mathematics from Harvard, a PhD from Yale in Molecular Biophysics and Biochemistry, and pursued postdoctoral studies at Caltech and UCSF.